Liposome Company
Executive Summary
Enters agreement with Mitsubishi Kasei Corp. covering the development of a delivery system for an undisclosed "proprietary peptide." Liposome will receive research fees and North American comarketing rights. Mitsubishi has exclusive rights in other parts of the world.